centigray.com - March 2005

Case Presentations

Adenocarcinoma of the right lung and the impact of high-dose IGRT

March 2005

PDF

Print

E-mail

Tawk RG, Duffy-Fronckowiak M, Scott BE, Alberico RA, Diaz AZ, Podgorsak MB, Plunkett RJ, Fenstermaker RA.
Stereotactic gamma knife surgery for trigeminal neuralgia: detailed analysis of treatment response. J Neurosurg. 2005 Mar;102(3):442-9.

Sheehan J, Pan HC, Stroila M, Steiner L.
Gamma knife surgery for trigeminal neuralgia: outcomes and prognostic factors. J Neurosurg. 2005 Mar;102(3):434-41.

Krishnan S, Foote RL, Brown PD, Pollock BE, Link MJ, Garces YI.
Radiosurgery for cranial base chordomas and chondrosarcomas. Neurosurgery. 2005 Apr;56(4):777-84; discussion 777-84.

Iwai Y, Yamanaka K, Yoshioka K.
Radiosurgery for nonfunctioning pituitary adenomas. Neurosurgery. 2005 Apr;56(4):699-705; discussion 699-705.

Muacevic A, Siebels M, Tonn JC, Wowra B.
Treatment of brain metastases in renal cell carcinoma: radiotherapy, radiosurgery, or surgery? World J Urol. 2005 Mar 25;

Reyes F, Lepage E, Ganem G, Molina TJ, Brice P, Coiffier B, Morel P, Ferme C, Bosly A, Lederlin P, Laurent G, Tilly H; Groupe d'Etude des Lymphomes de l'Adulte (GELA).
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med. 2005 Mar 24;352(12):1197-205.

Duncan GG, Epstein JB, Tu D, Sayed SE, Bezjak A, Ottaway J, Pater J.
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: A report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis. Head Neck. 2005 May;27(5):421-8.

Berger AC, Farma J, Scott WJ, Freedman G, Weiner L, Cheng JD, Wang H, Goldberg M.
Complete Response to Neoadjuvant Chemoradiotherapy in Esophageal Carcinoma Is Associated With Significantly Improved Survival. J Clin Oncol. 2005 Mar 21;

Wille S, Varga Z, von Knobloch R, Hofmann R.
Intussusception of bladder neck improves early continence after radical prostatectomy: results of a prospective trial. Urology. 2005 Mar;65(3):524-7.

Jani AB, Gratzle J, Muresan E, Farrey K, Martel MK.
Analysis of acute toxicity with use of transabdominal ultrasonography for prostate positioning during intensity-modulated radiotherapy. Urology. 2005 Mar;65(3):504-8.

El-Sherif A, Luketich JD, Landreneau RJ, Fernando HC.
New therapeutic approaches for early stage non-small cell lung cancer. Surg Oncol. 2005 Jul;14(1):27-32. Epub 2005 Jan 17.

Witham TF, Okada H, Fellows W, Hamilton RL, Flickinger JC, Chambers WH, Pollack IF, Watkins SC, Kondziolka D.
The Characterization of Tumor Apoptosis after Experimental Radiosurgery. Stereotact Funct Neurosurg. 2005 Mar 15;83(1):17-24

Loblaw DA, Perry J, Chambers A, Laperriere NJ.
Systematic review of the diagnosis and management of malignant extradural spinal cord compression: the Cancer Care Ontario Practice Guidelines Initiative's Neuro-Oncology Disease Site Group. J Clin Oncol. 2005 Mar 20;23(9):2028-37. Review.

Dotan ZA, Bianco FJ Jr, Rabbani F, Eastham JA, Fearn P, Scher HI, Kelly KW, Chen HN, Schoder H, Hricak H, Scardino PT, Kattan MW.
Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy. J Clin Oncol. 2005 Mar 20;23(9):1962-8.

Bellon JR, Come SE, Gelman RS, Henderson IC, Shulman LN, Silver BJ, Harris JR, Recht A.
Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol. 2005 Mar 20;23(9):1934-40.

Engelsman M, Sharp GC, Bortfeld T, Onimaru R, Shirato H.
How much margin reduction is possible through gating or breath hold? Phys Med Biol. 2005 Feb 7;50(3):477-90.

Gerszten PC, Germanwala A, Burton SA, Welch WC, Ozhasoglu C, Vogel WJ.
Combination kyphoplasty and spinal radiosurgery: a new treatment paradigm for pathological fractures. Neurosurg Focus. 2005 Mar 15;18(3):e8.

Leong T, Willis D, Joon DL, Condron S, Hui A, Ngan SY.
3D conformal radiotherapy for gastric cancer--results of a comparative planning study. Radiother Oncol. 2005 Mar;74(3):301-6.

Martin J, Fitzpatrick K, Horan G, McCloy R, Buckney S, O'Neill L, Faul C.
Treatment with a belly-board device significantly reduces the volume of small bowel irradiated and results in low acute toxicity in adjuvant radiotherapy for gynecologic cancer: results of a prospective study. Radiother Oncol. 2005 Mar;74(3):267-74.

Aass N, Fossa SD.
Pre- and post-treatment daily life function in patients with hormone resistant prostate carcinoma treated with radiotherapy for spinal cord compression. Radiother Oncol. 2005 Mar;74(3):259-65. Epub 2004 Dec 21.

Saarilahti K, Kouri M, Collan J, Hamalainen T, Atula T, Joensuu H, Tenhunen M.
Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function. Radiother Oncol. 2005 Mar;74(3):251-8.

Haie-Meder C, Potter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, Dumas I, Hellebust TP, Kirisits C, Lang S, Muschitz S, Nevinson J, Nulens A, Petrow P, Wachter-Gerstner N; Gynaecological (GYN) GEC-ESTRO Working Group.
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol. 2005 Mar;74(3):235-45.

Gerard JP.
The Estro Regaud Lecture. Radiotherapy in the conservative treatment of rectal cancer. Evidence-based medicine and opinion. Radiother Oncol. 2005 Mar;74(3):227-33.

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group.
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005 Mar 10;352(10):987-96.

Rutkowski S, Bode U, Deinlein F, Ottensmeier H, Warmuth-Metz M, Soerensen N, Graf N, Emser A, Pietsch T, Wolff JE, Kortmann RD, Kuehl J.
Treatment of early childhood medulloblastoma by postoperative chemotherapy alone. N Engl J Med. 2005 Mar 10;352(10):978-86.

Brown JR, Yeckes H, Friedberg JW, Neuberg D, Kim H, Nadler LM, Freedman AS.
Increasing incidence of late second malignancies after conditioning with cyclophosphamide and total-body irradiation and autologous bone marrow transplantation for non-Hodgkin's lymphoma. J Clin Oncol. 2005 Apr 1;23(10):2208-14. Epub 2005 Mar 7.

Park W, Lim do H, Paik SW, Koh KC, Choi MS, Park CK, Yoo BC, Lee JE, Kang MK, Park YJ, Nam HR, Ahn YC, Huh SJ.
Local radiotherapy for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1143-50.

Ferrigno R, Nakamura RA, Dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV, Filho WJ, Lopes A.
Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1136-42.

Allal AS, Gervaz P, Gertsch P, Bernier J, Roth AD, Morel P, Bieri S.
Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1129-35.

Prosnitz RG, Yao B, Farrell CL, Clough R, Brizel DM.
Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1087-95.

Schroder M, Mell LK, Hurteau JA, Collins YC, Rotmensch J, Waggoner SE, Yamada SD, Small W Jr, Mundt AJ.
Clitoral therapy device for treatment of sexual dysfunction in irradiated cervical cancer patients. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1078-86.

Suh WW, Hillner BE, Pierce LJ, Hayman JA.
Cost-effectiveness of radiation therapy following conservative surgery for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1054-61.

al-Abany M, Helgason AR, Cronqvist AK, Lind B, Mavroidis P, Wersall P, Lind H, Qvanta E, Steineck G.
Toward a definition of a threshold for harmless doses to the anal-sphincter region and the rectum. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1035-44.

Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, Lebesque JV, Koper PC.
Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1019-34.

Heemsbergen WD, Hoogeman MS, Hart GA, Lebesque JV, Koper PC.
Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1011-8.

Cheung R, Tucker SL, Lee AK, de Crevoisier R, Dong L, Kamat A, Pisters L, Kuban D.
Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):993-1002.

Moreton P, Kennedy B, Lucas G, Leach M, Rassam SM, Haynes A, Tighe J, Oscier D, Fegan C, Rawstron A, Hillmen P.
Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival. J Clin Oncol. 2005 May 1;23(13):2971-9. Epub 2005 Feb 28.

Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, Clarke-Pearson DL, Berchuck A.
Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer. J Clin Oncol. 2005 Feb 28;

Mamon HJ, Yeap BY, Janne PA, Reblando J, Shrager S, Jaklitsch MT, Mentzer S, Lukanich JM, Sugarbaker DJ, Baldini EH, Berman S, Skarin A, Bueno R.
High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol. 2005 Mar 1;23(7):1530-7.

Nguyen PL, Chakravarti A, Finkelstein DM, Hochberg FH, Batchelor TT, Loeffler JS.
Results of whole-brain radiation as salvage of methotrexate failure for immunocompetent patients with primary CNS lymphoma. J Clin Oncol. 2005 Mar 1;23(7):1507-13.

Smith BD, Smith GL, Haffty BG.
Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer. J Clin Oncol. 2005 Mar 1;23(7):1409-19.

Colleoni M, Zahrieh D, Gelber RD, Holmberg SB, Mattsson JE, Rudenstam CM, Lindtner J, Erzen D, Snyder R, Collins J, Fey MF, Thurlimann B, Crivellari D, Murray E, Mendiola C, Pagani O, Castiglione-Gertsch M, Coates AS, Price K, Goldhirsch A.
Site of primary tumor has a prognostic role in operable breast cancer: the international breast cancer study group experience. J Clin Oncol. 2005 Mar 1;23(7):1390-400.

Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Mazzarol G, Pruneri G, Luini A, Intra M, Veronesi P, Galimberti V, Torrisi R, Cardillo A, Goldhirsch A, Viale G.
Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol. 2005 Mar 1;23(7):1379-89.